secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cycurion, Inc. (CYCU)
CIK:        0001868419
Form:       8-K
Filed at:   2026-09-08T19:15:48+00:00
Accession:  0001628280-26-060880
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cycurion announces ~$800K annual contract spend from pharma AI, NACCHO, and other engagements
--------------------------------------------------------------------------------

- New engagements total approximately $800,000 in annual contract spend, first public announcement.
- Pharmaceutical organization engaged Cycurion to support an AI Center of Excellence.
- NACCHO awarded new work; Cycurion is a Diamond Affiliate Partner.
- Scope includes business continuity, cybersecurity assessments, program management, and AI operating capability.
- CEO L. Kevin Kelly: commercial healthcare and life-sciences are primary growth markets beyond government.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868419/000162828026060880/0001628280-26-060880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868419/000162828026060880/cycu-20260903.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-060880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer